AR125919A2 - SUSTAINED-RELEASE RUXOLITINIB DOSAGE FORMS - Google Patents

SUSTAINED-RELEASE RUXOLITINIB DOSAGE FORMS

Info

Publication number
AR125919A2
AR125919A2 ARP220101336A ARP220101336A AR125919A2 AR 125919 A2 AR125919 A2 AR 125919A2 AR P220101336 A ARP220101336 A AR P220101336A AR P220101336 A ARP220101336 A AR P220101336A AR 125919 A2 AR125919 A2 AR 125919A2
Authority
AR
Argentina
Prior art keywords
ruxolitinib
dosage forms
sustained
release
useful
Prior art date
Application number
ARP220101336A
Other languages
Spanish (es)
Inventor
Yong Ni
Bhavnish Parikh
Krishnaswamy Yeleswaram
Susan Erickson-Viitanen
William V Williams
Original Assignee
Incyte Holdings Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Holdings Corp filed Critical Incyte Holdings Corp
Publication of AR125919A2 publication Critical patent/AR125919A2/en

Links

Abstract

La presente invención se refiere a formulaciones de liberación sostenida y formas de dosificación de ruxolitinib o su sal farmacéuticamente aceptable, que son útiles en el tratamiento de enfermedades relacionadas con las quinasa Janus como trastornos mieloproliferativos.The present invention relates to sustained release formulations and dosage forms of ruxolitinib or its pharmaceutically acceptable salt, which are useful in the treatment of Janus kinase-related diseases such as myeloproliferative disorders.

ARP220101336A 2012-11-15 2022-05-19 SUSTAINED-RELEASE RUXOLITINIB DOSAGE FORMS AR125919A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261726893P 2012-11-15 2012-11-15
US202061769408P 2020-02-26 2020-02-26

Publications (1)

Publication Number Publication Date
AR125919A2 true AR125919A2 (en) 2023-08-23

Family

ID=87886787

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP220101336A AR125919A2 (en) 2012-11-15 2022-05-19 SUSTAINED-RELEASE RUXOLITINIB DOSAGE FORMS

Country Status (1)

Country Link
AR (1) AR125919A2 (en)

Similar Documents

Publication Publication Date Title
CR20150265A (en) DOSAGE FORMS OF SUSTAINED RUXOLITINIB LIBERATION
CY1124311T1 (en) DNA-PK INHIBITORS
CY1125436T1 (en) DNA-PK INHIBITORS
UY33616A (en) COMPOUNDS WITH IMIDAZOTRIAZINONA STRUCTURE
CL2014001752A1 (en) Substituted bicyclic compounds; pharmaceutical composition that includes them; and use in the treatment of diseases such as cancer, Alzheimer's, AIDS, among others.
UY33863A (en) METHODS AND MEDICINES FOR THE TREATMENT OF ALZHEIMER'S DISEASE
UA116648C2 (en) FUMARATS AS A PRODUCT AND THEIR USE IN THE TREATMENT OF DIFFERENT DISEASES
ECSP15001882A (en) NOVEL 5-AMINOTETRAHYDROQUINOLIN-2-CARBOXYLIC ACIDS AND THEIR USE
PE20151788A1 (en) TETRACYCLIC BROMODOMINES INHIBITORS
EA201591616A1 (en) TRIFTTOROMETHYL-SUBSTITUTED ANNELATED PYRIMIDINES AND THEIR APPLICATION
DOP2014000115A (en) USE OF SUBSTITUTED 4-PHENYL-PYRIDINS FOR THE MANUFACTURE OF USEFUL MEDICINES IN THE TREATMENT OF DISEASES RELATED TO THE NK1 RECEIVER
EA201500314A1 (en) DOSAGE FORMS OF ENZALUTAMIDE
EA201590343A1 (en) ALKYLPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND FURTHER DISEASES
PE20150092A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DIMETHYL FUMARATE
PE20121617A1 (en) OXAZINE DERIVATIVES AS BACE INHIBITORS
EA201500365A1 (en) COMBINATION OF REGORAPHENIBE AND ACETYLSALICYLIC ACID TO CURE CANCER
ECSP13012824A (en) DERIVATIVES OF (1,2,4) TRIAZOLO [4,3-A) QUINOXALINE AS PHOSPHODESTERASE INHIBITORS
UY36171A (en) BICYCLIC HETEROAROMATIC DERIVATIVES FUSED AS QUINASE INHIBITORS
EA201291211A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING HYDROMORPHONE AND NALOXONE
NI201600070A (en) AUTOTAXIN TETRAYCLIC INHIBITORS
DOP2014000114A (en) NOVEL 2HINDAZOLES AS EP2 RECEPTOR ANTAGONISTS
AR094851A1 (en) BICYCLIC COMPOUNDS AS S1P₁ AGONISTS
GB201213484D0 (en) Pharmaceutical compositions comprising 15-OHEPA and methods of using the same
TR201908151T4 (en) Isoindoline derivatives.
UA112488C2 (en) THREE (HETERO) ARILPYRAZOLES AND THEIR APPLICATIONS